Cargando…
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
The pathological hallmarks of Parkinson’s disease (PD) are α-synuclein (αSYN)-positive inclusions referred to as Lewy bodies and Lewy neurites, collectively referred to as Lewy-related pathology (LRP). LRP is thought to propagate in an ascending manner throughout the brain as the disease progresses....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450240/ https://www.ncbi.nlm.nih.gov/pubmed/36068646 http://dx.doi.org/10.1186/s40478-022-01440-6 |
_version_ | 1784784482458402816 |
---|---|
author | Sekiya, Hiroaki Tsuji, Asato Hashimoto, Yuki Takata, Mariko Koga, Shunsuke Nishida, Katsuya Futamura, Naonobu Kawamoto, Michi Kohara, Nobuo Dickson, Dennis W. Kowa, Hisatomo Toda, Tatsushi |
author_facet | Sekiya, Hiroaki Tsuji, Asato Hashimoto, Yuki Takata, Mariko Koga, Shunsuke Nishida, Katsuya Futamura, Naonobu Kawamoto, Michi Kohara, Nobuo Dickson, Dennis W. Kowa, Hisatomo Toda, Tatsushi |
author_sort | Sekiya, Hiroaki |
collection | PubMed |
description | The pathological hallmarks of Parkinson’s disease (PD) are α-synuclein (αSYN)-positive inclusions referred to as Lewy bodies and Lewy neurites, collectively referred to as Lewy-related pathology (LRP). LRP is thought to propagate in an ascending manner throughout the brain as the disease progresses. LRP is visible with histologic methods and is thought to represent a later stage of the disease process, while αSYN oligomers, which are not visible with routine histologic methods, are considered earlier. There is increasing evidence to suggest that αSYN oligomers may be more toxic than visible LRP. Detecting αSYN oligomers requires special techniques, and their distribution and association with clinical features are important research objectives. In this report, we describe the distribution of αSYN oligomers in multiple cortical and subcortical regions of PD using a proximity ligation assay (PLA). We observe widespread distribution of αSYN oligomers with PLA and more restricted distribution of LRP with αSYN immunohistochemistry. The distribution of αSYN oligomers differed from LRP in that αSYN oligomer burden was significantly greater in the neocortex, while LRP was greater in vulnerable subcortical regions, including the brainstem. We also found that cognitive impairment was associated with αSYN oligomers in the hippocampus. These results suggest that αSYN oligomers may be widely distributed in PD early in the disease process and that they may contribute to cognitive impairment in PD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01440-6. |
format | Online Article Text |
id | pubmed-9450240 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94502402022-09-08 Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease Sekiya, Hiroaki Tsuji, Asato Hashimoto, Yuki Takata, Mariko Koga, Shunsuke Nishida, Katsuya Futamura, Naonobu Kawamoto, Michi Kohara, Nobuo Dickson, Dennis W. Kowa, Hisatomo Toda, Tatsushi Acta Neuropathol Commun Research The pathological hallmarks of Parkinson’s disease (PD) are α-synuclein (αSYN)-positive inclusions referred to as Lewy bodies and Lewy neurites, collectively referred to as Lewy-related pathology (LRP). LRP is thought to propagate in an ascending manner throughout the brain as the disease progresses. LRP is visible with histologic methods and is thought to represent a later stage of the disease process, while αSYN oligomers, which are not visible with routine histologic methods, are considered earlier. There is increasing evidence to suggest that αSYN oligomers may be more toxic than visible LRP. Detecting αSYN oligomers requires special techniques, and their distribution and association with clinical features are important research objectives. In this report, we describe the distribution of αSYN oligomers in multiple cortical and subcortical regions of PD using a proximity ligation assay (PLA). We observe widespread distribution of αSYN oligomers with PLA and more restricted distribution of LRP with αSYN immunohistochemistry. The distribution of αSYN oligomers differed from LRP in that αSYN oligomer burden was significantly greater in the neocortex, while LRP was greater in vulnerable subcortical regions, including the brainstem. We also found that cognitive impairment was associated with αSYN oligomers in the hippocampus. These results suggest that αSYN oligomers may be widely distributed in PD early in the disease process and that they may contribute to cognitive impairment in PD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01440-6. BioMed Central 2022-09-06 /pmc/articles/PMC9450240/ /pubmed/36068646 http://dx.doi.org/10.1186/s40478-022-01440-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Sekiya, Hiroaki Tsuji, Asato Hashimoto, Yuki Takata, Mariko Koga, Shunsuke Nishida, Katsuya Futamura, Naonobu Kawamoto, Michi Kohara, Nobuo Dickson, Dennis W. Kowa, Hisatomo Toda, Tatsushi Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease |
title | Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease |
title_full | Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease |
title_fullStr | Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease |
title_full_unstemmed | Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease |
title_short | Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease |
title_sort | discrepancy between distribution of alpha-synuclein oligomers and lewy-related pathology in parkinson’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450240/ https://www.ncbi.nlm.nih.gov/pubmed/36068646 http://dx.doi.org/10.1186/s40478-022-01440-6 |
work_keys_str_mv | AT sekiyahiroaki discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT tsujiasato discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT hashimotoyuki discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT takatamariko discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT kogashunsuke discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT nishidakatsuya discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT futamuranaonobu discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT kawamotomichi discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT koharanobuo discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT dicksondennisw discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT kowahisatomo discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease AT todatatsushi discrepancybetweendistributionofalphasynucleinoligomersandlewyrelatedpathologyinparkinsonsdisease |